位置:首页 > 产品库 > Polyinosinic-polycytidylic acid sodium
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Polyinosinic-polycytidylic acid sodium
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Polyinosinic-polycytidylic acid sodium图片
CAS NO:42424-50-0

Poly(I:C) sodium
Polyinosinic-polycytidylic acid sodium (Poly(I:C) sodium) 是双链 RNA 的合成类似物,是一种TLR3和视黄酸诱导型基因 I 受体 (RIG-IMDA5) 的激动剂。Polyinosinic-polycytidylic acid sodium 可以用作疫苗佐剂,以增强先天性和适应性免疫反应,并改变肿瘤的微环境,还可以直接触发癌细胞发生凋亡。
生物活性

Polyinosinic-polycytidylic acid sodium (Poly(I:C) sodium) is a synthetic analog of double-stranded RNA and an agonist oftoll-like receptor 3(TLR3)andretinoic acid inducible gene I (RIG-I)-like receptors(RIG-IandMDA5). Polyinosinic-polycytidylic acid sodium can be used as a vaccine adjuvant to enhance innate and adaptive immune responses, and to alter the tumor microenvironment. Polyinosinic-polycytidylic acid sodium can directly triggercancercells to undergoapoptosis[1][2].

IC50& Target

TLR3

 

体外研究
(In Vitro)

Polyinosinic-polycytidylic acid (20 ng/mL; 24 hours; WM793, WM278, WM239A, WM9 and 1205Lu cells) treatment strongly reduces viability from 100% in controls to 20%–50% within 24 hours[1].
Polyinosinic-polycytidylic acid (200 ng/mL; 24 hours; 1205Lu cells) treatment induces apoptosis in 1205Lu cells[1].
Polyinosinic-polycytidylic acid (3 ng/mL; 24 hours; 1205Lu cells) treatment induces IFN-β expression in melanoma cells. Silencing of RIG-I and MDA-5 confirmed that induction of IFN-β by Polyinosinic-polycytidylic acid required RIG-I and MDA-5, respectively, and that required IPS-1[1].
Polyinosinic-polycytidylic acid (5 ng/mL; 24 hours; 1205Lu cells) treatment reveals active subunits of caspase-9 and caspase-8 in melanoma cells[1].
Polyinosinic-polycytidylic acid sodium is prepared for injection by resuspending in sterile saline, heating to 50 ℃ at a concentration of 2 mg/ml to ensure complete solubilisation and then allowing to cool naturally to room temperature to ensure proper annealing of double-stranded RNA. Poly I:C is stored at -20 ℃ until use[3].

Cell Viability Assay[1]

Cell Line:WM793, WM278, WM239A, WM9 and 1205Lu cells
Concentration:20 ng/mL
Incubation Time:24 hours
Result:Strongly reduced viability from 100% in controls to 20%–50% within 24 hours.

Apoptosis Analysis[1]

Cell Line:1205Lu cells
Concentration:200 ng/mL
Incubation Time:24 hours
Result:Induced apoptosis in 1205Lu cells.

RT-PCR[1]

Cell Line:1205Lu cells
Concentration:3 ng/mL
Incubation Time:24 hours
Result:Induced IFN-β expression in melanoma cells.

Western Blot Analysis[1]

Cell Line:1205Lu cells
Concentration:5 ng/mL
Incubation Time:24 hours
Result:Revealed active subunits of caspase-9 and caspase-8 in melanoma cells.
体内研究
(In Vivo)

Polyinosinic-polycytidylic acid treatment inhibits tumor growth in NOD/SCID immunodeficient mice injected with 1205Lu cells. The level of human DNA is 50% lower in mice treated with Polyinosinic-polycytidylic acid[1].

性状

Solid

Formula

(C10H13N4O8P)x.(C9H14N3O8P)x.xNa

CAS 号

42424-50-0

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

H2O : 10 mg/mL(Need ultrasonic and warming)

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: PBS

    Solubility: 6.67 mg/mL (Infinity mM); Clear solution; Need ultrasonic and warming and heat to 60℃

*以上所有助溶剂都可在本网站选购。
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024